secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Cognition Inc. (ACOG)
CIK:        0001655923
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001213900-26-045668
Event type: leadership
Sentiment:  positive
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alpha Cognition appoints Bethany Sensenig to board of directors
---------------------------------------------------------------

- Bethany Sensenig appointed director on April 15, 2026; previously CFO/Head of Ops at Radius Health.
- Sensenig also serves on boards of Supernus Pharmaceuticals (SUPN) and KalVista Pharmaceuticals (KALV).
- Received initial grant of 5,489 RSUs and 6,991 stock options (exercise price $6.65), vesting one year from grant.
- Sensenig spent 13 years at Biogen in senior finance roles with P&L accountability for over $1B annual revenue.
- Compensated per company's non-employee director compensation policy; no arrangements or family relationships.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1655923/000121390026045668/0001213900-26-045668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1655923/000121390026045668/ea028707001-8k_alphacog.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-045668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer